There’s more good news for the Cincinnati Innovation District. Orange Grove Bio, a preclinical drug investment and development firm that been had located in New York City, will move its corporate headquarters to the University of Cincinnati’s (UC) 1819 Innovation Hub.
Orange Grove Bio currently partners with more than 40 universities across the country — looking for treatments and technologies that it could spin off into subcompanies capable of developing novel therapeutics. That strategy allows Orange Grove to streamline and speed up the development process and get drugs to market faster.
Cincinnati provides Orange Grove Bio with direct access to the area’s research and commercialization talent, including Cincinnati Children’s Hospital Medical Center and UC Health.
Click here to learn more.